Rare diseases
Investigational molecules
Locations
Back to Czechia50 clinical trials in Teplice, Czechia across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in CzechiaKlinickeTesty.cz(opens in a new tab)Study of olpasiran to prevent first major cardiovascular events in people with high levels of lipoprotein(a)
CzechiaStudy of human normal immunoglobulin to prevent major infections in patients with hypogammaglobulinemia and autoimmune/rheumatic disease on B‑cell depletion therapy
CzechiaContinued Access Study for Patients with Neurological Disease Using Ocrelizumab and Drug Combination
CzechiaStudy on the Effects of Dexpramipexole for Adolescents and Adults with Severe Eosinophilic Asthma
CzechiaStudy on CAL02 and Sodium Chloride for Patients with Severe Community-Acquired Bacterial Pneumonia
CzechiaStudy of Verekitug to improve symptoms in patients with moderate to severe chronic obstructive pulmonary disease (COPD)
CzechiaStudy of AZD0780 in patients with high cholesterol and heart disease or risk of heart disease to lower bad cholesterol levels
CzechiaLong-Term Safety Study of Plozasiran for Adults with High Triglycerides
CzechiaStudy on the Effectiveness and Safety of Fluticasone Propionate and Salbutamol Sulfate for Asthma in Patients Aged 12 and Older
CzechiaStudy of Evolocumab to Prevent Heart Disease Events in High-Risk Patients Without Previous Heart Attack or Stroke
CzechiaStudy on the Effectiveness and Safety of CHF 5993 Compared to CHF 1535 for Patients with Chronic Obstructive Pulmonary Disease (COPD)
CzechiaStudy on the Safety of CHF5993 Inhaler with HFA-152a vs. HFA-134a in Patients with Moderate to Severe Asthma
CzechiaThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical research focusing on severe asthma and COPD treatments, evaluating new therapeutic approaches for patients with uncontrolled symptoms. Studies are examining various inhaler formulations and novel biological treatments to improve lung function and reduce exacerbations.
Multiple trials are investigating both established and experimental medications for treating moderate to severe respiratory conditions.
Comprehensive research programs investigating treatments for Multiple Sclerosis, including both relapsing-remitting and progressive forms. Studies are evaluating new therapeutic approaches and comparing different administration methods for existing treatments.
Advanced clinical trials focusing on improving treatment options and patient outcomes in neurological conditions.
Research initiatives examining treatments for Hypertriglyceridemia and related metabolic conditions. Studies are focused on evaluating the safety and efficacy of new therapeutic agents for managing lipid disorders.
Innovative clinical trials aimed at developing more effective treatments for metabolic disorders.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
